|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
2.600 0.000 (0.000%) | 2024/06 - Interim HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 339,205 | 382,786 | 409,161 | 299,238 |
| Net Cash from / (used in) Investing Activities | -- | (54,338) | (302,030) | (280,084) | (343,266) |
| Net Cash from / (used in) Financing Activities | -- | (309,925) | (169,110) | (73,132) | 149,485 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (25,058) | (88,355) | 55,945 | 105,458 |
| Cash & Cash Equivalents at beginning of period | -- | 543,486 | 671,336 | 599,782 | 473,341 |
| Effect of Foreign Exchange Rate Changes | -- | (8,583) | (39,494) | 15,609 | 20,983 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 509,845 | 543,486 | 671,336 | 599,782 |
| Remarks: | Real time quote last updated: 11/11/2024 09:54 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 157,440,000 |
| %Change | -7.285% |
| EPS / (LPS) | HKD 0.277 |
| NBV Per Share ($) | HKD 3.551 |